Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes
- PMID: 2510125
- DOI: 10.1007/BF00582134
Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes
Abstract
In a previous article (Escande et al. 1988a), we have shown that cromakalim (BRL 34915), a potassium channel opener (PCO), is a potent activator of ATP-sensitive K+ channels in cardiac cells. In the present article, the influence on K+ channels of two other potassium channel openers chemically unrelated to cromakalim, RP 49356 and pinacidil, has been investigated in patch-clamped isolated cardiac myocytes. In the whole-cell configuration, K+ currents were recorded in the presence of 50 microM TTX and 3 microM nitrendipine or 3 mM cobalt. Like cromakalim, RP 49356 or pinacidil activated a time-independent outward current at 33-35 degrees C but not at 19-21 degrees C, which showed little voltage-dependency in the potential range -60 to +60 mV. Its amplitude was a function of the agonist concentration, e.g. it was 2.1 +/- 0.4 nA at +60 mV with 30 microM RP 49356 and 4.3 +/- 0.8 nA with 300 microM. In control conditions, glibenclamide, a blocker of K+-ATP channels in pancreatic and heart cells, affected neither the inward rectifier, iK1, nor the delayed K+ current, iK. At 3 microM, glibenclamide fully prevented the effects of 300 microM RP 49356 or pinacidil. At lower concentrations, glibenclamide partially counteracted the activation by PCOs of a K+ current. In the cell-attached configuration, externally applied RP 49356 or pinacidil caused opening of large channels which reversed around O mV in a high K+ external medium. In inside-out patches, both RP 49356 or pinacidil activated K+-ATP channels by increasing the time period for which the channels remained in the open state. It is concluded that, like cromakalim, RP 49356 and pinacidil are potent activators of K+-ATP channels in cardiac myocytes.
Similar articles
-
Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.J Vasc Res. 1993 Jan-Feb;30(1):2-12. doi: 10.1159/000158969. J Vasc Res. 1993. PMID: 8435468
-
Effects of several potassium channel openers and glibenclamide on the uterus of the rat.Br J Pharmacol. 1990 Dec;101(4):901-7. doi: 10.1111/j.1476-5381.1990.tb14178.x. Br J Pharmacol. 1990. PMID: 2128195 Free PMC article.
-
Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.Eur J Pharmacol. 1989 Jun 20;165(2-3):231-9. doi: 10.1016/0014-2999(89)90717-6. Eur J Pharmacol. 1989. PMID: 2528466
-
Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.J Cardiovasc Pharmacol. 1994;24 Suppl 4:S12-7. J Cardiovasc Pharmacol. 1994. PMID: 7898103 Review.
-
Smooth muscle K+ channel openers; their pharmacology and clinical potential.Pflugers Arch. 1989;414 Suppl 1:S99-105. doi: 10.1007/BF00582256. Pflugers Arch. 1989. PMID: 2674897 Review. No abstract available.
Cited by
-
Selective modulation of the ATP-sensitive K+ channel by nicorandil in guinea-pig cardiac cell membrane.Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):592-7. doi: 10.1007/BF00169050. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2151053
-
Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo.Br J Pharmacol. 1991 Sep;104(1):71-6. doi: 10.1111/j.1476-5381.1991.tb12387.x. Br J Pharmacol. 1991. PMID: 1664766 Free PMC article.
-
ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats.Mol Cell Biochem. 1996 May 10;158(1):43-51. doi: 10.1007/BF00225881. Mol Cell Biochem. 1996. PMID: 8791283
-
The effect of glibenclamide on frog skeletal muscle: evidence for K+ATP channel activation during fatigue.J Physiol. 1994 Mar 15;475(3):495-507. doi: 10.1113/jphysiol.1994.sp020088. J Physiol. 1994. PMID: 8006831 Free PMC article.
-
Regulation of arterial tone by calcium-dependent K+ channels and ATP-sensitive K+ channels.Cardiovasc Drugs Ther. 1993 Aug;7 Suppl 3:605-10. doi: 10.1007/BF00877627. Cardiovasc Drugs Ther. 1993. PMID: 8251430 Review.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources